Dendrobium polysaccharide (DOP) ameliorates the LL‐37‐induced rosacea by inhibiting NF‐κB activation in a mouse model

Abstract

AbstractBackgroundRosacea, a common chronic inflammatory skin disease worldwide, is currently incurable with complex pathogenesis. Dendrobium polysaccharide (DOP) may exert therapeutic effects on rosacea via acting on the NF‐κB‐related inflammatory and oxidative processes.Materials and methodsIn this study, an LL‐37‐induced rosacea‐like mouse model was established. HE staining was used to assess the skin lesions, erythema severity scores, pathological symptoms, and inflammatory cell numbers of mice in each group. The inflammation level was quantitatively analyzed using enzyme‐linked immunosorbent assay (ELISA) and reverse transcription‐quantitative real‐time polymerase chain reaction (RT‐qPCR). The expression levels of TLR4 and p‐NF‐κB were finally detected.ResultsDOP improved skin pathological symptoms of rosacea mice. DOP also alleviated the inflammation of rosacea mice. Moreover, the TLR4/NF‐κB pathway was observed to be inhibited in the skin of mice after DOP application. These findings evidenced the anti‐inflammatory effects of DOP on the LL‐37‐induced rosacea mouse model. DOP could inhibit NF‐κB activation, suppress neutrophil infiltration, and reduce pro‐inflammatory cytokines production, which may be the reason for DOP protecting against rosacea.ConclusionThis study may propose an active candidate with great potential for rosacea drug development and lay a solid experimental foundation for promoting DOP application in rosacea therapy.